Clovis Oncology Appoints Two New Directors to its Board



Clovis Oncology, Inc. (NASDAQ: CLVS), announced today the appointment of

Robert W. Azelby and Richard A. Fair to the company’s Board of Directors.



"Clovis will be well served by the addition of these two individuals......
. .
Veröffentlicht von: Finanzen.at - Nachrichten Ticker - Thursday, 11 October
Share |